公司資料

IO Biotech 股價、新聞與催化劑

股票代碼:: IOBT
交易所:: NASDAQ
產業:: Biopharma
所在地:: Denmark

股價為何變動

Current closing-price context is not available for IOBT.

公司概覽

業務概覽

IO Biotech is an immuno-oncology company focused on cancer vaccines and immune-modulating therapies. Its platform aims to create differentiated immunotherapy in solid tumors.

所在地與產業分類

Headquartered in Denmark and listed on NASDAQ as an ADR, IO Biotech has a global oncology-biotech profile.

商業模式特徵

The company depends on clinical data, immune-response validation, and the ability to create a durable cancer-vaccine platform.

生技產業定位

IO Biotech is a catalyst-driven oncology name whose valuation depends on early clinical outcomes.

未來催化劑

IO Biotech’s catalysts are Cylembio and the cancer-vaccine program, especially any update that keeps the immuno-oncology platform moving. The company needs human data to support the thesis.